Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FUYDP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,740
Award facts
- Contract value 100% obligated
- $47,739.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,739.78 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose, 2 pens per milliliter. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 6, 2025. The award supports the federal government's pharmaceutical supply needs, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. All reviewed contract awards with AmerisourceBergen have been competitively awarded with firm fixed pricing, reflecting the company's established capability to meet federal procurement requirements. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic partner in supporting U.S. military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FUYDP?
SPE2DB25FUYDP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FUYDP worth?
The government has obligated $47,740 on SPE2DB25FUYDP.
Is contract SPE2DB25FUYDP an order under another contract?
Yes. SPE2DB25FUYDP is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB25FUYDP competed?
The extent of competition for SPE2DB25FUYDP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award